JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-04-30 浩瀚林海

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投了个case，10天就拒了，速度还挺快的

165 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-05-12 ms2000002096194073

哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2024-02-03 ms6000001766034942 来自山东省

投着投着显示面板看不见稿件任何信息了

24 0

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2023-10-31 ms3000000179629265 来自山西省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。

28 0

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2023-08-24 941739541 来自天津

偏重的研究方向：皮肤病
经验分享：请问半个月就awiting decision 是不是都没有送外审🤣

38 0

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2022-06-21 ms8000002026250184

5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。

180 0

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2022-05-21 小桥流水meitong

一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。

179 0

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-12-03 ms6000001037448610

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：性病;皮肤病
经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。

257 0

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-11-19 ms8000001304230869

投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。

201 0

[GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2020-06-09 ms7253200455804543

审稿速度:2.0
经验分享：审了2个月，拒了。然而也没有给出很好的建议。

191 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务